Our data, together with the data presented in Clark’s study [6], clearly points to the possibility of using ApoA-I staining in the diagnosis process of primary FSGS, both in the native kidney [6] and in recurrence after kidney transplantation. This evidence concerns the gene APOA1 and focal segmental glomerulosclerosis.